Unknown

Dataset Information

0

Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patients


ABSTRACT: Pharmacological blockade of the renin–angiotensin–aldosterone system (RAAS) with angiotensin-converting enzyme (ACE)-inhibitors and angiotensin receptor blockers (ARBs) are cornerstone treatments in several cardiovascular disease entities [1]. The RAAS is a central regulator of blood pressure, consisting of two counterregulatory pathways, commonly described as classical and nonclassical, respectively [1]. The main effect of classical RAAS activation is the generation of angiotensin (Ang)-II by ACE [1]. In contrast, non-classical RAAS activation results in cleavage of Ang-II by angiotensin converting enzyme-2 (ACE2) to form angiotensin 1–7, which directly counteracts the effects of classical RAAS activation [1]. Critically ill #COVID19 patients display markedly increased alternative angiotensin pathway activity compared to healthy controls, reflected by increased blood ACE2 levels as well as decreased angiotensin-II and enhanced angiotensin-1–7 formationhttps://bit.ly/2MU1z4z

SUBMITTER: van Lier D 

PROVIDER: S-EPMC7848790 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2022-02-28 | GSE197259 | GEO
| S-EPMC7214324 | biostudies-literature
| S-EPMC7796300 | biostudies-literature
2021-07-03 | GSE168400 | GEO
2023-04-29 | GSE206264 | GEO
| S-EPMC7478439 | biostudies-literature
| S-EPMC7938645 | biostudies-literature
| S-EPMC7269898 | biostudies-literature
| S-EPMC7908946 | biostudies-literature
2022-02-28 | GSE197258 | GEO